A RANGE of progenitor cells derived from healthy mouse small intestine tissue will be of particular interest to research groups using BME 2 organoid matrix and specialising in drug screening applications, says Amsbio. The company has extended its product range…
CRISPR/Cas gene editing is a relatively new technique which offers high accuracy in gene targeting and better target sequence selection, with less complexity and less off-target toxicity than previous genome editing technologies. Amsbio provides a standalone premade Cas9 expression lentivirus,…